Mitsubishi UFJ Trust & Banking’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$10.2M Buy
184,755
+32,036
+21% +$1.76M 0.02% 543
2025
Q1
$10.8M Sell
152,719
-2,116
-1% -$150K 0.03% 518
2024
Q4
$10.2M Sell
154,835
-55,073
-26% -$3.62M 0.02% 559
2024
Q3
$14.8M Buy
209,908
+25,899
+14% +$1.82M 0.03% 487
2024
Q2
$15.1M Buy
184,009
+4,812
+3% +$396K 0.04% 449
2024
Q1
$15.7M Sell
179,197
-7,982
-4% -$697K 0.04% 459
2023
Q4
$18M Buy
187,179
+7,999
+4% +$771K 0.04% 412
2023
Q3
$15.9M Sell
179,180
-3,607
-2% -$319K 0.04% 430
2023
Q2
$15.8M Buy
182,787
+1,866
+1% +$162K 0.04% 455
2023
Q1
$17.6M Buy
180,921
+2,541
+1% +$247K 0.04% 416
2022
Q4
$18.5M Buy
178,380
+403
+0.2% +$41.7K 0.05% 396
2022
Q3
$15.1M Sell
177,977
-41,295
-19% -$3.5M 0.04% 418
2022
Q2
$18.2M Buy
219,272
+29,638
+16% +$2.46M 0.05% 397
2022
Q1
$14.6M Sell
189,634
-14,698
-7% -$1.13M 0.03% 477
2021
Q4
$18.1M Buy
204,332
+91,876
+82% +$8.12M 0.04% 447
2021
Q3
$8.69M Buy
112,456
+2,632
+2% +$203K 0.02% 633
2021
Q2
$9.16M Sell
109,824
-11,720
-10% -$978K 0.02% 630
2021
Q1
$9.2M Sell
121,544
-21,979
-15% -$1.66M 0.02% 623
2020
Q4
$12.6M Buy
143,523
+6,795
+5% +$596K 0.03% 555
2020
Q3
$10.4M Sell
136,728
-3,537
-3% -$269K 0.02% 549
2020
Q2
$17.3M Sell
140,265
-2,622
-2% -$323K 0.04% 419
2020
Q1
$12.1M Buy
142,887
+8,390
+6% +$709K 0.04% 446
2019
Q4
$11.4M Sell
134,497
-1,224
-0.9% -$103K 0.03% 538
2019
Q3
$9.27M Sell
135,721
-3,403
-2% -$232K 0.02% 581
2019
Q2
$11.7M Buy
139,124
+5,356
+4% +$450K 0.04% 464
2019
Q1
$11.7M Buy
133,768
+323
+0.2% +$28.4K 0.04% 442
2018
Q4
$11.4M Buy
133,445
+2,046
+2% +$174K 0.05% 413
2018
Q3
$12.7M Sell
131,399
-223,991
-63% -$21.7M 0.05% 435
2018
Q2
$33.5M Buy
355,390
+2,448
+0.7% +$231K 0.06% 369
2018
Q1
$28.6M Buy
352,942
+934
+0.3% +$75.7K 0.05% 412
2017
Q4
$31.4M Buy
352,008
+66
+0% +$5.89K 0.05% 373
2017
Q3
$32.8M Buy
351,942
+9,225
+3% +$859K 0.06% 353
2017
Q2
$31.1M Sell
342,717
-24,242
-7% -$2.2M 0.06% 363
2017
Q1
$32.2M Buy
366,959
+5,577
+2% +$490K 0.06% 348
2016
Q4
$29.9M Buy
361,382
+32,043
+10% +$2.65M 0.06% 349
2016
Q3
$30.5M Buy
329,339
+7,082
+2% +$655K 0.06% 352
2016
Q2
$25.1M Buy
322,257
+5,566
+2% +$433K 0.06% 384
2016
Q1
$26.1M Buy
316,691
+2,813
+0.9% +$232K 0.06% 365
2015
Q4
$32.9M Buy
313,878
+2,971
+1% +$311K 0.08% 304
2015
Q3
$32.7M Buy
310,907
+7,476
+2% +$787K 0.08% 289
2015
Q2
$41.5M Buy
303,431
+9,487
+3% +$1.3M 0.1% 239
2015
Q1
$36.6M Buy
293,944
+25,460
+9% +$3.17M 0.09% 280
2014
Q4
$24.3M Buy
268,484
+10,436
+4% +$943K 0.06% 378
2014
Q3
$18.6M Sell
258,048
-14,378
-5% -$1.04M 0.05% 441
2014
Q2
$16.9M Buy
272,426
+4,084
+2% +$254K 0.04% 490
2014
Q1
$18.3M Buy
268,342
+8,108
+3% +$553K 0.04% 449
2013
Q4
$18.3M Buy
260,234
+2,250
+0.9% +$158K 0.05% 451
2013
Q3
$18.6M Buy
257,984
+25,594
+11% +$1.85M 0.05% 425
2013
Q2
$13M Buy
+232,390
New +$13M 0.04% 503